Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 146–146 | Cite as

Cyclophosphamide/doxorubicin/paclitaxel

Various toxicities: 6 case reports
Case report
  • 17 Downloads

Reference

  1. Nishimura M, et al. Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel. Anticancer Research 39: 4379-4383, No. 8, Aug 2019. Available from: URL: http://doi.org/10.21873/anticanres.13607 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations